We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
-3%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$61.2B
AUM Growth
-$925M
(-1.5%)
Cap. Flow
+$1.83B
Cap. Flow
% of AUM
3%
Top 10 Holdings %
Top 10 Hldgs %
34%
Holding
4,182
New
205
Increased
1,228
Reduced
1,725
Closed
203
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.09B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$404M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$242M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$226M |
| 5 |
Vanguard Total Bond Market
BND
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$740M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$260M |
| 3 |
Apple
AAPL
|
+$50.2M |
| 4 |
Microsoft
MSFT
|
+$33.4M |
| 5 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Healthcare | 8.38% |
| 3 | Financials | 7% |
| 4 | Industrials | 5.3% |
| 5 | Consumer Staples | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
BridgeBio Pharma
BBIO
$16.4B
| $547K | ﹤0.01% |
20,736
-9,460
| -31% | -$268K |
|
1327
DNP Select Income Fund
DNP
$4.14B
| $545K | ﹤0.01% |
57,241
-860
| -1% | -$8.67K |
|
1328
Omnicell
OMCL
$1.88B
| $544K | ﹤0.01% |
12,073
-8,145
| -40% | -$493K |
|
1329
New Oriental
EDU
$9.32B
| $542K | ﹤0.01% |
9,253
+3,196
| +53% | +$168K |
|
1330
Fox Class A
FOXA
$24.8B
| $541K | ﹤0.01% |
17,345
-1,052
| -6% | -$34.6K |
|
|
HCP
1331
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $541K | ﹤0.01% |
23,679
-5,041
| -18% | -$137K |
|
1332
Vanguard FTSE Europe ETF
VGK
$30.1B
| $540K | ﹤0.01% |
9,317
+435
| +5% | +$26.5K |
|
1333
Sixth Street Specialty
TSLX
$1.67B
| $540K | ﹤0.01% |
26,398
| – | – |
|
1334
Great Southern Bancorp
GSBC
$878M
| $539K | ﹤0.01% |
11,252
-118
| -1% | -$6.14K |
|
1335
Old National Bancorp
ONB
$10.2B
| $539K | ﹤0.01% |
37,055
-1,939
| -5% | -$30K |
|
1336
GoodRx Holdings
GDRX
$1.09B
| $537K | ﹤0.01% |
95,353
+1,363
| +1% | +$9.09K |
|
1337
Omega Healthcare
OHI
$15.3B
| $537K | ﹤0.01% |
16,182
+1,086
| +7% | +$34.7K |
|
1338
HNI Corp
HNI
$3.08B
| $535K | ﹤0.01% |
15,435
-1,357
| -8% | -$41.8K |
|
1339
Meritage Homes
MTH
$4.78B
| $534K | ﹤0.01% |
8,726
-1,546
| -15% | -$106K |
|
1340
FNB Corp
FNB
$6.76B
| $533K | ﹤0.01% |
49,431
-2,234
| -4% | -$26.3K |
|
|
TBHC
1341
DELISTED
The Brand House Collective
TBHC
| $533K | ﹤0.01% |
310,000
| – | – |
|
1342
Advanced Energy
AEIS
$10.1B
| $531K | ﹤0.01% |
5,151
+2,048
| +66% | +$229K |
|
1343
UFP Industries
UFPI
$4.95B
| $531K | ﹤0.01% |
5,187
-35
| -0.7% | -$3.54K |
|
1344
iShares Core MSCI Pacific ETF
IPAC
$2.59B
| $530K | ﹤0.01% |
9,540
| – | – |
|
1345
Omega Flex
OFLX
$292M
| $530K | ﹤0.01% |
6,736
+362
| +6% | +$31.3K |
|
1346
SI-BONE Inc
SIBN
$818M
| $530K | ﹤0.01% |
24,931
-1,774
| -7% | -$41.1K |
|
1347
Liberty Media Series C
FWONK
$25.5B
| $528K | ﹤0.01% |
8,474
+1,164
| +16% | +$79.9K |
|
1348
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $528K | ﹤0.01% |
23,868
+12,448
| +109% | +$282K |
|
1349
American States Water
AWR
$3.44B
| $526K | ﹤0.01% |
6,690
-257
| -4% | -$21.9K |
|
1350
10x Genomics
TXG
$5.88B
| $526K | ﹤0.01% |
12,743
-567
| -4% | -$29.5K |
|
Similar funds
US Bancorp's Q3 2023 Portfolio in Review
As of Q3 2023, US Bancorp held 4,182 positions worth $61.2B, down 1.5% from $62.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
US Bancorp's Q3 2023 filing shows 205 new, 1,228 increased, 1,725 reduced and 203 closed positions. Its largest new stake was Bahl & Gaynor Income Growth ETF: 122,630 shares worth $2.91M. The largest sale was Vanguard Total International Stock ETF, an estimated $740M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
- US Bancorp's largest Q3 2023 buy was Bahl & Gaynor Income Growth ETF: 122,630 shares worth $2.91M.
- US Bancorp added most to Vanguard Short-Term Corporate Bond ETF in Q3 2023, an estimated $1.09B increase.
- US Bancorp's biggest Q3 2023 reduction was Vanguard Total International Stock ETF, cutting an estimated $740M.
- US Bancorp fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $7.5M.
- US Bancorp's ten largest holdings make up 34% of its $61.2B portfolio in Q3 2023.
- US Bancorp opened 205 new positions and closed 203 in Q3 2023.
- US Bancorp's portfolio value fell 1.5% quarter-over-quarter to $61.2B.
Based on US Bancorp's 13F filing for Q3 2023, filed 3 Nov 2023.